# CONVERGE - Epi/Endo Ablation For Treatment of Persistent Atrial Fibrillation(AF)

Study · id `cardio:ct-nct01984346` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01984346](<https://clinicaltrials.gov/study/NCT01984346>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01984346

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 170 participants.

## Technical summary

Registry record NCT01984346. Randomized; no masking; primary purpose treatment. Start 2013-12 (registry gives no type); primary completion 2019-08 (actual). Results posted on 2022-02-10.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 170 participants (enrolled count; ClinicalTrials.gov record NCT01984346, source copy `cardio:ctgov-nct01984346-2023-11-13`, retrieved 2026-10-26)
- Start date: 2013-12 (registry gives no type) (ClinicalTrials.gov record NCT01984346, source copy `cardio:ctgov-nct01984346-2023-11-13`, retrieved 2026-10-26)
- Primary completion: 2019-08 (actual) (ClinicalTrials.gov record NCT01984346, source copy `cardio:ctgov-nct01984346-2023-11-13`, retrieved 2026-10-26)
- Completion: 2023-10 (actual) (ClinicalTrials.gov record NCT01984346, source copy `cardio:ctgov-nct01984346-2023-11-13`, retrieved 2026-10-26)
- Results first posted: 2022-02-10 (ClinicalTrials.gov record NCT01984346, source copy `cardio:ctgov-nct01984346-2023-11-13`, retrieved 2026-10-26)
- Countries: United States; United Kingdom (ClinicalTrials.gov record NCT01984346, source copy `cardio:ctgov-nct01984346-2023-11-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01984346-2023-11-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: CONVERGE - Epi/Endo Ablation For Treatment of Persistent Atrial Fibrillation(AF)
- Acronym: CONVERGE
- Condition: Persistent Atrial Fibrillation
- Intervention (Device): AtriCure EPi-Sense-AF Guided Coagulation System with VisiTrax
- Intervention (Device): Endocardial RF Catheter ablation using Open Irrigated-tip RF Abaltion Catheter with unidirectional or bidirectional steering
- Lead sponsor: AtriCure, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: AtriCure, Inc. (`cardio:org-atricure-inc`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Hybrid Convergent Procedure for the Treatment of Persistent and Long-Standing Persistent Atrial Fibrillation: Results of CONVERGE Clinical Trial (`cardio:pubmed-33185144`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 2d31a6c264d6613550bb478a7ada165802ef2f29e43d6acb6ef9ed9b293ee24c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
